Effect of papillary and chromophobe cell type on disease-free survival after nephrectomy for renal cell carcinoma

被引:219
作者
Beck, SDW
Patel, MI
Snyder, ME
Kattan, MW
Motzer, RJ
Reuter, VE
Russo, P
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Urol, Sidney Kimmel Ctr Prostate & Urol Canc, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA
[3] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA
[4] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA
关键词
kidney cancer; histology; metastases; staging;
D O I
10.1007/BF02524349
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The clinical staging of renal cortical tumors traditionally has not evaluated the potential effect of histological subtypes on survival. Evidence suggests that conventional clear cell renal cell carcinoma (RCC) and nonconventional clear cell RCC (chromophobe and papillary) have different metastatic potential. Using a large renal tumor database, we examined the effect of tumor histology on the pattern of metastasis and patient survival. Methods: All patients with nonmetastatic renal cortical tumors undergoing partial or radical nephrectomy were identified from a renal tumor database between July 1989 and July 2002. Kaplan-Meier and Cox regression tests were used for statistical analysis. Results: Analysis revealed 1057 patients: 794 with conventional clear cell RCC, 157 with papillary RCC, and 106 with chromophobe RCC. Metastasis occurred in 95 conventional clear cell RCC, 9 papillary RCC, and 6 chromophobe RCC with a median follow-up of 34.6, 43.0, and 33.2 months, respectively. Using log-rank analysis, chromophobe and papillary RCC were associated with an improved disease-free survival at 5 years (P = .009 and .015, respectively). Multivariate analysis revealed tumor size, stage, and chromophobe histology as significant variables for disease progression. Conclusions: Renal cortical tumors have distinct histological subtypes with varying degrees of metastatic potential. Conventional clear cell RCC, which comprises two thirds of renal cortical tumors presenting with localized disease, has a less favorable outcome when compared with papillary and chromophobe RCC. Controlling for size and stage, chromophobe, and not papillary, RCC was a significant variable for disease progression compared with conventional clear cell RCC. Knowledge of renal cortical tumor histological subtype is critical for projecting prognosis, tailoring follow-up strategies, and designing clinical trials.
引用
收藏
页码:71 / 77
页数:7
相关论文
共 54 条
[1]   CHROMOPHOBE CELL-CARCINOMA OF THE KIDNEY - A CLINICOPATHOLOGICAL STUDY OF 21 CASES [J].
AKHTAR, M ;
KARDAR, H ;
LINJAWI, T ;
MCCLINTOCK, J ;
ALI, MA .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1995, 19 (11) :1245-1256
[2]   Renal oncocytoma: A reappraisal of morphologic features with clinicopathologic findings in 80 cases [J].
Amin, MB ;
Crotty, TB ;
Tickoo, SK ;
Farrow, GM .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1997, 21 (01) :1-12
[3]   Papillary (chromophil) renal cell carcinoma: Histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 62 cases [J].
Amin, MB ;
Corless, CL ;
Renshaw, AA ;
Tickoo, SK ;
Kubus, J ;
Schultz, DS .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1997, 21 (06) :621-635
[4]   Prognostic impact of histologic Subtyping of adult renal epithelial neoplasms - An experience of 405 cases [J].
Amin, MB ;
Amin, MB ;
Tamboli, P ;
Javidan, J ;
Stricker, H ;
Venturina, MD ;
Deshpande, A ;
Menon, M .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2002, 26 (03) :281-291
[5]  
Bugert P, 1997, LAB INVEST, V76, P203
[6]   CHROMOPHOBE CELL RENAL-CARCINOMA - CLINICOPATHOLOGICAL FEATURES OF 50 CASES [J].
CROTTY, TB ;
FARROW, GM ;
LIEBER, MM .
JOURNAL OF UROLOGY, 1995, 154 (03) :964-967
[7]  
Delahunt B, 1997, MODERN PATHOL, V10, P537
[8]   Morphologic typing of papillary renal cell carcinoma: Comparison of growth kinetics and patient survival in 66 cases [J].
Delahunt, B ;
Eble, JN ;
McCredie, MRE ;
Bethwaite, PB ;
Stewart, JH ;
Bilous, AM .
HUMAN PATHOLOGY, 2001, 32 (06) :590-595
[9]   PAPILLARY RENAL-CELL CARCINOMA - CLINICAL IMPLICATION OF DNA CONTENT-ANALYSIS [J].
ELNAGGAR, AK ;
RO, JY ;
ENSIGN, LG .
HUMAN PATHOLOGY, 1993, 24 (03) :316-321
[10]   SOMATIC MUTATIONS OF THE VON HIPPEL-LINDAU DISEASE TUMOR-SUPPRESSOR GENE IN NONFAMILIAL CLEAR-CELL RENAL-CARCINOMA [J].
FOSTER, K ;
PROWSE, A ;
VANDENBERG, A ;
FLEMING, S ;
HULSBEEK, MMF ;
CROSSEY, PA ;
RICHARDS, FM ;
CAIRNS, P ;
AFFARA, NA ;
FERGUSONSMITH, MA ;
BUYS, CHCM ;
MAHER, ER .
HUMAN MOLECULAR GENETICS, 1994, 3 (12) :2169-2173